“Orally administered fisetin as an immuno-modulatory and therapeutic agent in a mouse model of chronic allergic airway disease”, Biomed. Res. Ther., vol. 6, no. 7, pp. 3262–3273, Jul. 2019, doi: 10.15419/bmrat.v6i7.553.